Beyond the Pharmacy of the World: Why India's Biopharma Ambition Requires a Regulatory Revolution
The historical trajectory of global biopharmaceuticals reveals a recurring pattern: major regulatory systems rarely undergo structural leaps purely out of administrative foresight. Almost invariably, systems are transformed after a crisis exposes the true economic and human cost of weak oversight.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
